Get the Stockscreener App
10.47
0.48%
0.0182
Adapthealth Corp stock is traded at $10.47, with a volume of 35,994.
It is up +0.48% in the last 24 hours and down -17.97% over the past month.
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company operates under four reportable segments that align with its product categories: (i) Sleep Health, (ii) Respiratory Health, (iii) Diabetes Health, and (iv) Wellness at Home. The company generates majority of its revenue from the Sleep Health segment. The Sleep Health segment provides sleep therapy equipment, supplies and related services (including continuous positive airway pressure and BiLevel services) to individuals for the treatment of obstructive sleep apnea.
See More
Previous Close:
$10.45
Open:
$10.4
24h Volume:
35,994
Relative Volume:
0.02
Market Cap:
$1.42B
Revenue:
$3.24B
Net Income/Loss:
$-66.64M
P/E Ratio:
-19.72
EPS:
-0.5308
Net Cash Flow:
$219.38M
1W Performance:
+1.45%
1M Performance:
-17.97%
6M Performance:
+9.26%
1Y Performance:
+19.59%
1-Day Range:
$10.35
$10.51
1-Week Range:
$10.11
$10.57
52-Week Range:
$8.06
$13.43
Adapthealth Corp Stock (AHCO) Company Profile
Name
Adapthealth Corp
Sector
Industry
Phone
610-424-4515
Address
555 EAST NORTH LANE, CONSHOHOCKEN, PA
Compare AHCO vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AHCO
Adapthealth Corp
|
10.47 | 1.42B | 3.24B | -66.64M | 219.38M | -0.5308 |
ABT
Abbott Laboratories
|
86.05 | 152.25B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
311.51 | 121.33B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
77.90 | 100.91B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.34 | 85.88B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.90 | 49.39B | 6.30B | 1.07B | 1.09B | 1.8406 |
Adapthealth Corp Stock (AHCO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-24 | Downgrade | Jefferies | Buy → Hold |
| Nov-08-23 | Downgrade | BofA Securities | Neutral → Underperform |
| May-10-23 | Downgrade | Deutsche Bank | Buy → Hold |
| May-10-23 | Downgrade | Stifel | Buy → Hold |
| May-09-23 | Downgrade | BofA Securities | Buy → Neutral |
| Sep-27-21 | Initiated | SVB Leerink | Outperform |
| Jul-14-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Apr-13-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-18-21 | Initiated | Truist | Buy |
| Jan-26-21 | Initiated | BofA Securities | Buy |
| Dec-10-20 | Initiated | UBS | Buy |
| Aug-10-20 | Initiated | Canaccord Genuity | Buy |
| Jul-01-20 | Resumed | SVB Leerink | Outperform |
| Jun-09-20 | Initiated | RBC Capital Mkts | Outperform |
| Jan-31-20 | Initiated | Stifel | Buy |
| Jan-07-20 | Initiated | Jefferies | Buy |
| Dec-11-19 | Initiated | SVB Leerink | Outperform |
| Dec-10-19 | Initiated | Deutsche Bank | Buy |
View All
Adapthealth Corp Stock (AHCO) Latest News
How Adapthealth Corp. (AHCO) Affects Rotational Strategy Timing - Stock Traders Daily
AHCO Stock Price, Quote & Chart | ADAPTHEALTH CORP (NASDAQ:AHCO) - ChartMill
What's Driving the Recent Buzz Around AdaptHealth (AHCO) - Kavout
Repligen, AdaptHealth, and IQVIA Stocks Trade Down, What You Need To Know - Yahoo Finance
AdaptHealth Corp.Common Stock (NQ: AHCO - The Chronicle-Journal
The Top 5 Analyst Questions From AdaptHealth’s Q1 Earnings Call - Yahoo Finance
Canaccord Lifts PT on AdaptHealth Corp. (AHCO) Following Q1 Results - Insider Monkey
Transcript : AdaptHealth Corp. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 09 - marketscreener.com
AdaptHealth Conference: Kaiser Deal Drives Growth, Labor Costs Dent EBITDA - MarketBeat
Senior Health, Home Health & Hospice Stocks Q1 Highlights: AdaptHealth (NASDAQ:AHCO) - Yahoo Finance
AdaptHealth's Labor Headwinds Lead to Fast Onboarding of Capitated Contract, RBC Says - marketscreener.com
AHCO Maintained by RBC Capital -- Price Target Raised to $15.00 - GuruFocus
(AHCO) and the Role of Price-Sensitive Allocations - Stock Traders Daily
AdaptHealth (AHCO) reports earnings tomorrow: What to expect - MSN
AdaptHealth Corp. (NASDAQ:AHCO) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
AdaptHealth Corp. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:AHCO) 2026-05-09 - Seeking Alpha
A Look At AdaptHealth (AHCO) Valuation As Investor Interest And Price Targets Diverge - Yahoo Finance
AdaptHealth (AHCO) Boosts 2026 Outlook and Refinances Debt Is Its Growth Strategy Evolving? - Sahm
AHCO | AdaptHealth Corp. Common Stock FinancialsIncome Statement - Quiver Quantitative
AHCO Investor News: Rosen, Trusted National Trial Counsel, Encourages AdaptHealth Corp. f/k/a DFB Healthcare Acquisitions Corp. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class ActionAHCO, A - TMX Newsfile
Stocks making big moves yesterday: Cogent, AdaptHealth, BWX, IQVIA, and Palantir Technologies - StockStory
Deutsche Bank Adjusts AdaptHealth Price Target to $12 From $9.50, Maintains Hold Rating - marketscreener.com
AdaptHealth (AHCO) Q1 2026 Earnings Transcript - AOL.com
AdaptHealth Corp. (NASDAQ:AHCO) Q1 2026 Earnings Call Transcript - Insider Monkey
Why AdaptHealth (AHCO) shares are sliding today - MSN
AdaptHealth Q1 2026 slides: organic growth surges amid margin pressure By Investing.com - Investing.com Australia
About Us - FinancialContent
AHCO Q1 Deep Dive: Capitated Growth Boosts Revenue, Margin Pressures Persist - StockStory
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of AdaptHealth Corp. f/k/a DFB Healthcare Acquisitions Corp. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 27, 2021AHCO - TMX Newsfile
AdaptHealth Corp. Q1 2026 Earnings Call Summary - Yahoo Finance
[10-Q] AdaptHealth Corp. Quarterly Earnings Report - Stock Titan
AdaptHealth Corp. to Participate in Upcoming Investor Conferences - The Joplin Globe
AdaptHealth schedules two investor fireside chats in May, with webcasts - Stock Titan
Why AdaptHealth (AHCO) Shares Are Sliding Today - StockStory
AdaptHealth Q1 2026 slides: organic growth surges amid margin pressure - Investing.com
Earnings call transcript: AdaptHealth Q1 2026 results miss EPS, stock drops - Investing.com Nigeria
AdaptHealth Releases Q1 2026 Financial Results - AlphaStreet
AdaptHealth Q1 Earnings Call Highlights - Yahoo Finance
AdaptHealth sets stage for ‘defining year’ - HME News
AHCO: Record patient transition drove revenue above guidance, with margin set to improve as costs normalize - TradingView
Earnings call transcript: AdaptHealth Q1 2026 results miss EPS, stock drops By Investing.com - Investing.com South Africa
AdaptHealth : Q1 Financial document(0001628280 26 030120.htm) - marketscreener.com
AdaptHealth Corp. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
AdaptHealth Seeks Acquisitions - marketscreener.com
AHCO: Net revenue grew 5.4% year-over-year, but net loss and leverage increased in Q1 2026 - TradingView
AdaptHealth (NASDAQ:AHCO) Beats Q1 CY2026 Sales Expectations - TradingView
ADAPTHEALTH ($AHCO) Releases Q1 2026 Earnings - Quiver Quantitative
AdaptHealth falls on Q1 loss despite revenue beat By Investing.com - Investing.com Australia
AdaptHealth falls on Q1 loss despite revenue beat - Investing.com
Adapthealth Corp Stock (AHCO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Adapthealth Corp Stock (AHCO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| CASHIN RICHARD M JR | 10% Owner |
Mar 19 '26 |
Buy |
9.94 |
727 |
7,228 |
15,865,598 |
| Prast Albert A. | Chief Technology Officer |
Mar 13 '26 |
Option Exercise |
4.38 |
89,451 |
391,795 |
532,358 |
| CASHIN RICHARD M JR | 10% Owner |
Mar 10 '26 |
Buy |
9.73 |
820,528 |
7,982,671 |
14,638,708 |
| CASHIN RICHARD M JR | 10% Owner |
Mar 12 '26 |
Buy |
9.73 |
689,336 |
6,707,170 |
15,864,871 |
| CASHIN RICHARD M JR | 10% Owner |
Mar 11 '26 |
Buy |
9.73 |
536,827 |
5,222,307 |
15,175,535 |
| WOLF DALE B | Director |
Feb 27 '26 |
Buy |
8.96 |
8,000 |
71,680 |
104,235 |
| Rew Richard W. II | CLO and General Counsel |
Feb 26 '26 |
Buy |
8.91 |
5,000 |
44,550 |
107,097 |
| Williams David Solomon III | Director |
Dec 04 '25 |
Sale |
9.43 |
5,000 |
47,150 |
45,045 |
0.32%
0.17%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):